Angioplasty Balloons Market Size, Share, Trend Analysis & Competition Tracking, Forecast 2018-2026


Angioplasty balloons are medical devices that are used during surgical procedures to unblock and enlarge congested blood arteries.

                Angioplasty Balloons Market



Angioplasty balloons are medical devices that are used during surgical procedures to unblock and enlarge congested blood arteries. Drug-eluting, normal, scoring, and cutting balloons are some of the most popular types of angioplasty balloons. They're made of nylon, polyurethane, and silicone urethane polymers, and they have nitinol constraining structures on the balloon's surface that generate grooves and pillows for predictable, uniform, and atraumatic dilation. The balloon is inflated during surgery to flatten the plaque against the blood artery walls, opening them and restoring normal blood flow.

According to a survey conducted by the Health Protection Agency in 2016, around 610,000 individuals die in the United States each year as a result of cardiac abnormalities, with the number continuing to rise. According to the World Health Organization (WHO), the United States had roughly 8 million people with peripheral artery disease in 2011. Coronary heart disease is the leading cause of death in the country, accounting for over half of all deaths. Over the predicted period, the prevalence of these disorders is expected to rise. Furthermore, a rising elderly population with heart disease and diabetes is predicted to drive up demand for angioplasty balloon catheters over the forecast period.

Market Segmentation:

By product type
  • Normal Balloons
  • Scoring Balloons
  • Drug-eluting balloon
  • Cutting balloon

By application
  • Coronary
  • Peripheral

By end-user
  • Hospitals
  • Ambulatory surgical centers
  • Catheterization labs

The angioplasty balloon market in Asia-emerging Pacific's economies offers significant opportunities for key players because the market is characterised by fierce competition, global availability, and user-friendliness, creating a favourable environment for all key players to grow, thereby boosting the global market's growth.


Some of the key players in the angioplasty balloon market includes NATEC Medical, Cook Medical, Medtronic plc, C.R. Bard Inc., Boston Scientific Corporation, Spectranetics Corporation, ENDOCOR GmbH, BIOTRONIK SE & CO. KG, Cordis Corporation, Abbott Laboratories, and Opto Circuits Ltd.

Comments

Post a Comment

Popular posts from this blog

Flavors and Fragrances Market: A Comprehensive Analysis of Current Trends and Future Outlook

Image
  Flavors and Fragrances Market Introduction: The global flavors and fragrances market has witnessed remarkable growth in recent years, driven by increasing consumer preferences for enhanced sensory experiences in various industries. Flavors and fragrances play a vital role in food and beverages, personal care products, household products, and the pharmaceutical industry. This report provides an in-depth analysis of the flavors and fragrances market, highlighting key trends, market dynamics, and future prospects. Market Overview: The flavors and fragrances market has experienced substantial growth, with a projected CAGR of X% from 2023 to 2028. The market is primarily driven by rising disposable incomes, urbanization, and changing consumer lifestyles. Key market players are continually investing in research and development activities to introduce innovative flavors and fragrances that cater to evolving consumer demands. Segmentation and Key Market Players: The market can be
Read more

Exploring the Different Types of Blood Clotting Factors and Their Functions

Image
  Blood Clotting Factor Coagulation, another name for blood clotting, is a complicated process that is essential for reducing excessive bleeding after an injury. It entails a chain of events that cause a blood clot to develop, sealing the injured blood artery and stopping further bleeding. Blood clotting factors are a group of proteins that control these processes. Roman numerals from I to XIII are used to identify each of the 13 distinct blood clotting factors. The liver makes them, and platelets, the tiny blood cells that aid in blood clotting, also make some of them. Each of these elements interacts with the others in a series of reactions, activating the one before it. Factor I : Also known as fibrinogen, is a protein that is converted into fibrin, the main component of a blood clot. Factor II, also known as prothrombin, is converted into thrombin, which converts fibrinogen into fibrin. Factor III, also known as tissue factor, is released by damaged tissue and initiates the clo
Read more